The Effects Of Pioglitazone And MK886 ON THE Mrna EXPRESSION OF PPAR-alpha, PPAR-gamma And Its Associated GENES, Cell Death And Migration In MDA-MB- 231 Cancer Cells

Pioglitazone (PGZ) is a prescription drug used in the treatment of diabetes mellitus type II. It is a well-known synthetic agonist for PP AR, and being studied extensively by our research group as a target drug for the treatment of ER-negative breast cancer. The ER-negative breast cancer is more...

Full description

Saved in:
Bibliographic Details
Main Author: Nadarajan, Kalpanah
Format: Thesis
Language:English
Published: 2015
Subjects:
Online Access:http://eprints.usm.my/56796/1/00001792017%20Kalpanah%20a.p%20Nadarajan.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-usm-ep.56796
record_format uketd_dc
spelling my-usm-ep.567962023-02-07T01:46:32Z The Effects Of Pioglitazone And MK886 ON THE Mrna EXPRESSION OF PPAR-alpha, PPAR-gamma And Its Associated GENES, Cell Death And Migration In MDA-MB- 231 Cancer Cells 2015-10 Nadarajan, Kalpanah R Medicine RC254-282 Neoplasms. Tumors. Oncology (including Cancer) Pioglitazone (PGZ) is a prescription drug used in the treatment of diabetes mellitus type II. It is a well-known synthetic agonist for PP AR, and being studied extensively by our research group as a target drug for the treatment of ER-negative breast cancer. The ER-negative breast cancer is more aggressive and fast growing than the ERpositive breast cancer. Moreover, this type of cancer has a poor prognosis generally and is often unresponsive to anti-estrogen therapy. A preliminary research showed that treatment of MDA-MB-231 with PGZ produced little effect on cell growth and did not induce apoptosis in the cancer cells despite increasing the levels of PPARa mRNA expression in the cells. As such, to further evaluate the role of the PPARa mRNA expression in MDA-MB-231, the effects of paz and MK886 on the induction and inhibition of inRNA expression of PPARa, respectively, and other associated genes in MDA:.MB-231 were determined in this study. The biological mechanisms induced by both drugs were also assessed in this study. To achieve all objectives of the study, the mRNA expression levels of PPARa in PGZ-treated and MK886-treated MDA-MB-231 were determined using Real-Time PCR; the growth inhibitory effects of PGZ and MK886 in MDA-MB-231 were determined using the Trypan Blue Exclusion Assay and Real-time PCR; the apoptosis induction by PGZ and MK886 in MDA-MB-231 was determined using the DNA Fragmentation Assay, Real-Time PCR, cell staining and Flow Cytometry, and the migration of PGZ-treated and MK886-treated MDA-MB-231 was determined using the Wound Healing Assay. 2015-10 Thesis http://eprints.usm.my/56796/ http://eprints.usm.my/56796/1/00001792017%20Kalpanah%20a.p%20Nadarajan.pdf application/pdf en public masters Perpustakaan Hamzah Sendut Institut Penyelidikan Perubatan Molekul
institution Universiti Sains Malaysia
collection USM Institutional Repository
language English
topic R Medicine
R Medicine
spellingShingle R Medicine
R Medicine
Nadarajan, Kalpanah
The Effects Of Pioglitazone And MK886 ON THE Mrna EXPRESSION OF PPAR-alpha, PPAR-gamma And Its Associated GENES, Cell Death And Migration In MDA-MB- 231 Cancer Cells
description Pioglitazone (PGZ) is a prescription drug used in the treatment of diabetes mellitus type II. It is a well-known synthetic agonist for PP AR, and being studied extensively by our research group as a target drug for the treatment of ER-negative breast cancer. The ER-negative breast cancer is more aggressive and fast growing than the ERpositive breast cancer. Moreover, this type of cancer has a poor prognosis generally and is often unresponsive to anti-estrogen therapy. A preliminary research showed that treatment of MDA-MB-231 with PGZ produced little effect on cell growth and did not induce apoptosis in the cancer cells despite increasing the levels of PPARa mRNA expression in the cells. As such, to further evaluate the role of the PPARa mRNA expression in MDA-MB-231, the effects of paz and MK886 on the induction and inhibition of inRNA expression of PPARa, respectively, and other associated genes in MDA:.MB-231 were determined in this study. The biological mechanisms induced by both drugs were also assessed in this study. To achieve all objectives of the study, the mRNA expression levels of PPARa in PGZ-treated and MK886-treated MDA-MB-231 were determined using Real-Time PCR; the growth inhibitory effects of PGZ and MK886 in MDA-MB-231 were determined using the Trypan Blue Exclusion Assay and Real-time PCR; the apoptosis induction by PGZ and MK886 in MDA-MB-231 was determined using the DNA Fragmentation Assay, Real-Time PCR, cell staining and Flow Cytometry, and the migration of PGZ-treated and MK886-treated MDA-MB-231 was determined using the Wound Healing Assay.
format Thesis
qualification_level Master's degree
author Nadarajan, Kalpanah
author_facet Nadarajan, Kalpanah
author_sort Nadarajan, Kalpanah
title The Effects Of Pioglitazone And MK886 ON THE Mrna EXPRESSION OF PPAR-alpha, PPAR-gamma And Its Associated GENES, Cell Death And Migration In MDA-MB- 231 Cancer Cells
title_short The Effects Of Pioglitazone And MK886 ON THE Mrna EXPRESSION OF PPAR-alpha, PPAR-gamma And Its Associated GENES, Cell Death And Migration In MDA-MB- 231 Cancer Cells
title_full The Effects Of Pioglitazone And MK886 ON THE Mrna EXPRESSION OF PPAR-alpha, PPAR-gamma And Its Associated GENES, Cell Death And Migration In MDA-MB- 231 Cancer Cells
title_fullStr The Effects Of Pioglitazone And MK886 ON THE Mrna EXPRESSION OF PPAR-alpha, PPAR-gamma And Its Associated GENES, Cell Death And Migration In MDA-MB- 231 Cancer Cells
title_full_unstemmed The Effects Of Pioglitazone And MK886 ON THE Mrna EXPRESSION OF PPAR-alpha, PPAR-gamma And Its Associated GENES, Cell Death And Migration In MDA-MB- 231 Cancer Cells
title_sort effects of pioglitazone and mk886 on the mrna expression of ppar-alpha, ppar-gamma and its associated genes, cell death and migration in mda-mb- 231 cancer cells
granting_institution Perpustakaan Hamzah Sendut
granting_department Institut Penyelidikan Perubatan Molekul
publishDate 2015
url http://eprints.usm.my/56796/1/00001792017%20Kalpanah%20a.p%20Nadarajan.pdf
_version_ 1776101174801334272